2C-T-7
| Clinical data | |
|---|---|
| Other names | 2,5-Dimethoxy-4-propylthiophenethylamine; 2,5-Dimethoxy-4-propylsulfanylphenethylamine; 4-Propylthio-2,5-dimethoxyphenethylamine; 4-Propylsulfanyl-2,5-dimethoxyphenethylamine; Blue Mystic; Tweety-Bird Mescaline |
| Routes of administration | Oral |
| Drug class | Serotonin 5-HT2 receptor agonist; Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Duration of action | 8–15 hours |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C13H21NO2S |
| Molar mass | 255.38 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 206 to 207 °C (403 to 405 °F) |
| |
| |
| (verify) | |
2C-T-7, also known as 4-propylthio-2,5-dimethoxyphenethylamine or as Blue Mystic or 7th Heaven, is a psychedelic drug of the phenethylamine and 2C families. It is taken orally.
2C-T-7 was first described in the scientific literature by Myron Stolaroff in 1990. It was developed by Alexander Shulgin and colleagues and was described in greater detail by them in 1991, including in Shulgin's book PiHKAL (Phenethylamines I Have Known and Loved).